NCT03500172

Brief Summary

The Siyaphambili Study is a sequential multistage adaptive randomized trial (SMART) to compare the effectiveness and durability of two behavioral interventions on the HIV-1 virologic response among female sex workers (FSW) living with HIV in Durban, South Africa. The interventions are: 1) nurse-led decentralized treatment program (DTP) and 2) individualized case management (ICM). Viral suppression is defined as a viral load assessment \<50 RNA copies/mL. The design will also estimate the incremental cost-effectiveness of study interventions and combinations of interventions compared with maintaining the South African standard of HIV care and treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,391

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

June 22, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2022

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

September 21, 2023

Completed
Last Updated

January 14, 2026

Status Verified

December 1, 2025

Enrollment Period

3.4 years

First QC Date

April 9, 2018

Results QC Date

May 31, 2023

Last Update Submit

December 19, 2025

Conditions

Keywords

HIVFemale Sex WorkersViral SuppressionSouth AfricaDecentralized careAntiretroviral therapyDifferentiated care

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants Retained and Virally Suppressed Among Those Receiving the DTP Versus ICM Arms

    Retention and viral suppression at 18 months in those initially randomized to DTP vs. ICM. Participants are considered to be retained in care if they attended their 18-month final study visit and were engaged in care at 18-months. Viral suppression is defined as having less than 50 viral copies per milliliter.

    18 months after enrollment

Secondary Outcomes (10)

  • Retention and Viral Suppression of Non-Responders

    18 months after enrollment

  • Risk Factors of Loss to Follow-up

    Up to 18 months after enrollment

  • Durability of Retention and Viral Suppression of Responders

    Up to 18 months after enrollment

  • Adherence Assessment

    18 months

  • Viral Suppression of Retained

    Up to 18 months after enrollment

  • +5 more secondary outcomes

Other Outcomes (3)

  • Decentralized Treatment Provision (DTP) Pick-Ups

    Up to 18 months after enrollment

  • ICM Phone-Based Contacts

    Up to 18 months after enrollment

  • ICM In-Person Meetings

    Up to 18 months after enrollment

Study Arms (9)

DTP, Continue DTP if Responsive

ACTIVE COMPARATOR

DTP: * Standard of care (SoC), minus clinic referrals for antiretroviral therapy (ART) treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Continues with DTP intervention if virally suppressed at 6 months.

Behavioral: DTP

DTP, Standard of Care (SoC) if Responsive

ACTIVE COMPARATOR

DTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services SoC: * HIV counseling and testing (HTC) * Sexually transmitted infection (STI) screening and treatment * Tuberculosis (TB) screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to Department of Health (DoH) primary healthcare clinics or TB HIV Care (THC) drop-in center for ART treatment initiation and management Returns to SoC if virally suppressed at 6 months.

Behavioral: DTP

DTP, Continue DTP if Non-Responsive

ACTIVE COMPARATOR

DTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Continues with DTP intervention if not virally suppressed at 6 months.

Behavioral: DTP

DTP, DTP+ICM if Non-Responsive

ACTIVE COMPARATOR

DTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through female sex worker (FSW) initiated interaction Receives both interventions at 6 months if non-virally suppressed.

Behavioral: DTPBehavioral: ICM

ICM, Continue ICM if Responsive

ACTIVE COMPARATOR

ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction Continues with ICM intervention at 6 months if virally suppressed.

Behavioral: ICM

ICM, SoC if Responsive

ACTIVE COMPARATOR

ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction SoC: * HIV counseling and testing (HTC) * STI screening and treatment * TB screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to DOH primary healthcare clinics or THC drop-in center for ART treatment initiation and management Returns to SoC if virally suppressed at 6 months.

Behavioral: ICM

ICM, Continue ICM if Non-Responsive

ACTIVE COMPARATOR

ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction Continues with ICM intervention at 6 months if non-virally suppressed.

Behavioral: ICM

ICM, ICM+DTP if Non-Responsive

ACTIVE COMPARATOR

ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction DTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Receives both interventions at 6 months if non-virally suppressed.

Behavioral: DTPBehavioral: ICM

Standard of Care (SoC)

NO INTERVENTION

Standard of Care (SoC): * HIV counseling and testing (HTC) * Sexually transmitted infection (STI) screening and treatment * Tuberculosis (TB) screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to Department of Health (DoH) primary healthcare clinics or TB HIV Care (THC) drop-in center for ART treatment initiation and management

Interventions

DTPBEHAVIORAL

Provision of antiretroviral therapy (ART) in the community through a mobile-van DTP managed by a nurse capable of initiating and managing ART.

DTP, Continue DTP if Non-ResponsiveDTP, Continue DTP if ResponsiveDTP, DTP+ICM if Non-ResponsiveDTP, Standard of Care (SoC) if ResponsiveICM, ICM+DTP if Non-Responsive
ICMBEHAVIORAL

Peer-led ICM through quarterly face-to-face meetings, monthly phone calls and biweekly text messages.

DTP, DTP+ICM if Non-ResponsiveICM, Continue ICM if Non-ResponsiveICM, Continue ICM if ResponsiveICM, ICM+DTP if Non-ResponsiveICM, SoC if Responsive

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly cisgender women will be enrolled into the study.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sells sex for goods or money as their main source of income
  • Assigned female sex at birth
  • ≥ 18 years of age
  • Living with HIV; diagnosed ≥ 6 months prior
  • Currently living in Durban
  • If on ART, initiated ≥2 months prior

You may not qualify if:

  • Engagement in an ongoing HIV treatment research study
  • Planning on leaving Durban for more than 3 months in the following 12 months
  • Pregnant at time of enrollment
  • On a second line or third ART regimen
  • Participating in an adherence club

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

TB HIV Care

Durban, South Africa

Location

Related Publications (5)

  • Comins CA, Genberg B, Mcingana M, Bandeen-Roche K, Phetlhu DR, Steingo J, Mishra S, Wang L, Baral S, Hausler H, Schwartz S. Longitudinal Trajectories of Engagement With HIV Treatment Support Strategies Among Female Sex Workers Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2025 Dec 1;100(4):323-330. doi: 10.1097/QAI.0000000000003738.

  • Comins CA, Baral S, Mcingana M, Shipp L, Phetlhu DR, Young K, Guddera V, Hausler H, Schwartz S. ART coverage and viral suppression among female sex workers living with HIV in eThekwini, South Africa: Baseline findings from the Siyaphambili study. PLOS Glob Public Health. 2024 May 22;4(5):e0002783. doi: 10.1371/journal.pgph.0002783. eCollection 2024.

  • Bhardwaj A, Comins CA, Guddera V, Mcingana M, Young K, Phetlhu R, Mulumba N, Mishra S, Hausler H, Baral S, Schwartz S. Prevalence of depression, syndemic factors and their impact on viral suppression among female sex workers living with HIV in eThekwini, South Africa. BMC Womens Health. 2023 May 5;23(1):232. doi: 10.1186/s12905-023-02392-2.

  • Chen C, Baral S, Comins CA, Mcingana M, Wang L, Phetlhu DR, Mulumba N, Guddera V, Young K, Mishra S, Hausler H, Schwartz SR. HIV- and sex work-related stigmas and quality of life of female sex workers living with HIV in South Africa: a cross-sectional study. BMC Infect Dis. 2022 Dec 6;22(1):910. doi: 10.1186/s12879-022-07892-4.

  • Wang L, Dowdy DW, Comins CA, Young K, Mcingana M, Mulumba N, Mhlophe H, Chen C, Hausler H, Schwartz SR, Baral S, Mishra S; Siyaphambili Study team. Health-related quality of life of female sex workers living with HIV in South Africa: a cross-sectional study. J Int AIDS Soc. 2022 Feb;25(2):e25884. doi: 10.1002/jia2.25884.

Limitations and Caveats

A limitation to this study has been determining engagement in care and viral load status for those who were lost to follow up (LTFU) in the trial in order to inform the primary outcome. Given the high rates of LTFU, participants may have been seeking care elsewhere and achieved viral suppression during the follow up period without our knowledge. This has implications for our primary outcome which uses an intention to treat (ITT) analysis of engagement in care and viral suppression.

Results Point of Contact

Title
Dr. Stefan Baral
Organization
Johns Hopkins Bloomberg School of Public Health

Study Officials

  • Stefan Baral, MD, MPH

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR
  • Harry Hausler, MD, MPH

    TB HIV Care

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: This sequential multistage adaptive randomized trial (SMART) assesses two interventions to address treatment barriers: (1) nurse-led mobile decentralized treatment programs (DTP) and (2) peer-led, individualized case management (ICM).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 17, 2018

Study Start

June 22, 2018

Primary Completion

November 24, 2021

Study Completion

January 5, 2022

Last Updated

January 14, 2026

Results First Posted

September 21, 2023

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations